JP2013543893A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543893A5
JP2013543893A5 JP2013540991A JP2013540991A JP2013543893A5 JP 2013543893 A5 JP2013543893 A5 JP 2013543893A5 JP 2013540991 A JP2013540991 A JP 2013540991A JP 2013540991 A JP2013540991 A JP 2013540991A JP 2013543893 A5 JP2013543893 A5 JP 2013543893A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutical composition
patient
radezolide
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013540991A
Other languages
English (en)
Japanese (ja)
Other versions
JP6370550B2 (ja
JP2013543893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/061643 external-priority patent/WO2012071324A2/en
Publication of JP2013543893A publication Critical patent/JP2013543893A/ja
Publication of JP2013543893A5 publication Critical patent/JP2013543893A5/ja
Application granted granted Critical
Publication of JP6370550B2 publication Critical patent/JP6370550B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013540991A 2010-11-24 2011-11-21 薬学的組成物 Active JP6370550B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41680710P 2010-11-24 2010-11-24
US61/416,807 2010-11-24
PCT/US2011/061643 WO2012071324A2 (en) 2010-11-24 2011-11-21 Pharmaceutical compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016243035A Division JP2017081950A (ja) 2010-11-24 2016-12-15 薬学的組成物

Publications (3)

Publication Number Publication Date
JP2013543893A JP2013543893A (ja) 2013-12-09
JP2013543893A5 true JP2013543893A5 (enExample) 2018-06-07
JP6370550B2 JP6370550B2 (ja) 2018-08-08

Family

ID=46146374

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013540991A Active JP6370550B2 (ja) 2010-11-24 2011-11-21 薬学的組成物
JP2016243035A Pending JP2017081950A (ja) 2010-11-24 2016-12-15 薬学的組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016243035A Pending JP2017081950A (ja) 2010-11-24 2016-12-15 薬学的組成物

Country Status (21)

Country Link
US (2) US20140088164A1 (enExample)
EP (1) EP2642996B1 (enExample)
JP (2) JP6370550B2 (enExample)
KR (1) KR101944124B1 (enExample)
CN (1) CN103391778B (enExample)
AU (1) AU2011332031B2 (enExample)
BR (1) BR112013012833A8 (enExample)
CA (1) CA2818249C (enExample)
EA (1) EA027791B1 (enExample)
ES (1) ES2836809T3 (enExample)
HU (1) HUE052801T2 (enExample)
IL (1) IL226378A0 (enExample)
MX (1) MX350565B (enExample)
MY (2) MY171941A (enExample)
NZ (1) NZ610638A (enExample)
PH (1) PH12013501069A1 (enExample)
PT (1) PT2642996T (enExample)
SG (2) SG10201509530YA (enExample)
UA (1) UA113722C2 (enExample)
WO (1) WO2012071324A2 (enExample)
ZA (1) ZA201303732B (enExample)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US5895663A (en) 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
PE20011088A1 (es) * 2000-03-22 2001-10-04 Upjohn Co Tratamiento de infecciones del tracto urinario con oxazolidinonas antibacterianas
EP1265608B1 (en) * 2000-03-22 2008-10-29 Pharmacia & Upjohn Company LLC Oxazolidinone tablet formulation
NZ522990A (en) 2000-06-05 2003-08-29 Dong A Pharm Novel oxazolidinone derivatives and a process for the preparation thereof
AU2001267011B2 (en) * 2000-06-21 2006-02-02 Cubist Pharmaceuticals, Inc. Compositions and methods to improve the oral absorption of antimicrobial agents
PL362979A1 (en) 2000-12-11 2004-11-02 Takeda Chemical Industries, Ltd. Medicinal compositions improved in solublity in water
JP2002241268A (ja) * 2000-12-11 2002-08-28 Takeda Chem Ind Ltd 水溶解性が改善された医薬組成物
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
TW200534879A (en) * 2004-03-25 2005-11-01 Bristol Myers Squibb Co Coated tablet formulation and method
NZ580951A (en) * 2005-04-29 2011-06-30 Cubist Pharm Inc Therapeutic compositions
EP1912730A2 (en) 2005-07-28 2008-04-23 Isp Investments Inc. Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
EP1909763A2 (en) 2005-07-28 2008-04-16 Isp Investments Inc. Benzoquinones of enhanced bioavailability
US20070104785A1 (en) * 2005-07-29 2007-05-10 Navale Suryakant V Tablets of linezolid form iii and processes for their preparation
CN101378731B (zh) * 2006-02-09 2014-03-05 默沙东公司 Cetp抑制剂的聚合物制剂
UY30535A1 (es) * 2006-08-10 2008-03-31 Cipla Ltd Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones.
US20120208857A1 (en) * 2009-10-13 2012-08-16 Burak Eric S Pharmaceutical Compositions
WO2011159626A1 (en) * 2010-06-14 2011-12-22 Bend Research, Inc. Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
WO2012061360A2 (en) * 2010-11-01 2012-05-10 Rib-X Pharmaceuticals, Inc. Pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2014533733A5 (enExample)
HRP20150838T1 (hr) Sastavi koji sadrže modulatore receptora sfingozin 1 fosfata (s1p)
JP2017528507A5 (enExample)
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
JP2016537347A5 (enExample)
JP2017528503A5 (enExample)
JP2018162255A5 (enExample)
JP2012532874A5 (enExample)
JP2010536849A5 (enExample)
JP2014532647A5 (enExample)
NO20073853L (no) Faste, oralt applikerbare farmasoytiske administreringsformer inneholdende nvaroksaban med modifisert frigivelse
JP2014521735A5 (enExample)
JP2012502885A5 (enExample)
CN115803328A (zh) 哌嗪-2,3-二酮衍生物及其在医药上的应用
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
CN114072404A (zh) Ret选择性抑制剂及其制备方法和用途
JP2006514611A5 (enExample)
JP2015510916A5 (enExample)
JP2017522300A5 (enExample)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
CN113905735A (zh) 神经激肽-1拮抗剂
JP2016530238A5 (enExample)
JP2015522603A5 (enExample)
JP2010500284A5 (enExample)
JP2023531930A5 (enExample)